Patents by Inventor Aaron W. Bell

Aaron W. Bell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9981048
    Abstract: The presently disclosed invention is directed to the discovery that hepatocyte nuclear factor 4 alpha (HNF4?; also known as NR2A1), a transcription factor, reverses hepatocyte dysfunction in an animal model of cirrhosis, resulting in improvement in hepatic function, treatment of cirrhosis, and prolonged survival.
    Type: Grant
    Filed: February 11, 2014
    Date of Patent: May 29, 2018
    Assignee: UNIVERSITY OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION
    Inventors: Ira Jacob Fox, Aaron W. Bell, Taichiro N. Nishikawa, Alejandro Soto-Gutierrez, Yoram Vodovotz
  • Publication number: 20140249209
    Abstract: The presently disclosed invention is directed to the discovery that hepatocyte nuclear factor 4 alpha (HNF4?; also known as NR2A1), a transcription factor, reverses hepatocyte dysfunction in an animal model of cirrhosis, resulting in improvement in hepatic function, treatment of cirrhosis, and prolonged survival.
    Type: Application
    Filed: February 11, 2014
    Publication date: September 4, 2014
    Applicant: University of Pittsburgh - of the Commonwealth System of Higher Education
    Inventors: Ira Jacob Fox, Aaron W. Bell, Taichiro N. Nishikawa, Alejandro Soto-Gutierrez